用于优化急性髓性白血病治疗的蛋白质组:venetoclax加上低甲基化剂与传统化疗相比
Eduardo Sabino de Camargo Magalhães1, Stefan Edward Hubner2, Brandon Douglas Brown3
1Department of Ageing Biology/ERIBA, University of Groningen, University Medical Center Groningen, Groningen, 9713 AV, the Netherlands.
Leukemia
|March 27, 2024
概括
使用蛋白质表达特征的新蛋白质组策略可以帮助选择急性髓性白血病 (AML) 患者的最佳治疗方法,改善结果并可能挽救生命. 这种方法指导了基于Venetoclax的疗法和常规化疗之间的治疗选择.
科学领域:
- 血液学 血液学 血液学
- 蛋白质组学是指蛋白质组学.
- 在瘤学瘤学.
背景情况:
- 与低甲基化剂 (VH) 结合的Venetoclax改善了急性髓性白血病 (AML) 治疗结果.
- 然而,并非所有AML患者都能从VH治疗中受益,因此需要个性化治疗选择策略.
- 需要合理的方法来选择VH和常规化疗 (CC) 之间的个人患者.
研究的目的:
- 开发一种基于蛋白质组的选策略,以优化新诊断成年AML患者的治疗选择.
- 确定预后性蛋白质表达特征和预测性生物标志物,用于VH或CC治疗反应.
- 评估蛋白质基导治疗选择策略对患者结果的潜在临床影响.
主要方法:
- 利用逆相蛋白质阵列 (RPPA) 来分析810名新诊断成年AML患者中的411种蛋白质的表达.
- 采用机器学习算法来识别一个由14种蛋白质组成的小组,能够推治疗.
- 根据预后蛋白质,评估了患者分为五个不同的表达特征的分层.
主要成果:
- 确定了109种预后蛋白质,定义了五种不同的患者表达特征,有助于治疗选择.
- 使用机器学习开发了14种蛋白质签名,用于准确的治疗建议,适合临床应用.
- 发现了一组对VH和CC无反应的患者,这表明有针对性治疗的潜力.
- 预计临床实施可以改变30%的患者的治疗方法,将整体存活率 (OS) 提高43%.
结论:
- 使用RPPA和机器学习的基于蛋白质组的分类策略可以有效地指导AML的治疗选择.
- 这种方法有可能显著改善AML患者的整体存活率并增加AML患者的治愈率.
- 确定了对AML患者的一个子集的替代治疗策略的需求,这些患者对当前的标准治疗没有反应.
相关概念视频
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
02:57Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
02:49Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K